Artventive Medical Group Inc (AVTD) Financial Statements (2024 and earlier)

Company Profile

Business Address 2766 GATEWAY ROAD
CARLSBAD, CA 92009
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments610225320980
Cash and cash equivalents610225320980
Inventory, net of allowances, customer advances and progress billings47311303304197 
Inventory47311303304197 
Prepaid expense4612111
Other undisclosed current assets82518577184
Total current assets:66353355416478166
Noncurrent Assets
Property, plant and equipment153817151614
Other undisclosed noncurrent assets656821159729
Total noncurrent assets:21939913011443
TOTAL ASSETS:86446453546591209
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,6471,4459246044761,554
Employee-related liabilities    00 
Accounts payable1,6471,445924604476484
Accrued liabilities      1,071
Debt    500  
Due to related parties500     
Other undisclosed current liabilities(500)  (500) 0
Total current liabilities:1,6471,4459246044761,554
Noncurrent Liabilities
Long-term debt and lease obligation500500500500500500
Long-term debt, excluding current maturities500500500500500500
Total noncurrent liabilities:500500500500500500
Total liabilities:2,1471,9451,4241,1049762,054
Equity
Equity, attributable to parent, including:(2,060)(1,499)(971)(558)(385)(1,845)
Additional paid in capital17,08817,04317,02916,67915,92213,498
Accumulated deficit    (17,300)(16,369)(15,403)
Other undisclosed equity, attributable to parent(19,148)(18,542)(17,999)636260
Total equity:(2,060)(1,499)(971)(558)(385)(1,845)
TOTAL LIABILITIES AND EQUITY:86446453546591209

Income Statement (P&L) ($ in thousands)

9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
Revenues194622509464
Cost of revenue
(Cost of Goods and Services Sold)
(19)(46)(22)(50)(94)(64)
Gross profit:      
Operating expenses(526)(543)(766)(930)(964)888
Other undisclosed operating income (loss)   3(1)(1)(1,776)
Operating loss:(526)(543)(763)(931)(965)(888)
Loss from continuing operations:(526)(543)(763)(931)(965)(888)
Loss before gain (loss) on sale of properties:(526)(543)(763)(931)(965)(888)
Net loss:(526)(543)(763)(931)(965)(888)
Other undisclosed net income attributable to parent   0  0
Net loss attributable to parent:(526)(543)(763)(931)(965)(888)
Other undisclosed net income (loss) available to common stockholders, basic   (0)00 
Net loss available to common stockholders, diluted:(526)(543)(763)(931)(965)(888)

Comprehensive Income ($ in thousands)

9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
Net loss:(526)(543)(763)(931)(965)(888)
Comprehensive loss:(526)(543)(763)(931)(965)(888)
Other undisclosed comprehensive income, net of tax, attributable to parent   0000
Comprehensive loss, net of tax, attributable to parent:(526)(543)(763)(931)(965)(888)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: